TargetMol

Bremazocine

Product Code:
 
TAR-T26902
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T26902-5mg5mg£1,167.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Bremazocineis a potent opiate kappa-agonist and centrally acting analgesic.
CAS:
75684-07-0
Formula:
C20H29NO2
Molecular Weight:
315.457
Purity:
0.98
SMILES:
[H][C@]12Cc3ccc(O)cc3C(CC)(CCN1CC1(O)CC1)C2(C)C

References

1. Petrillo P, Gambino MC, Tavani A. Bremazocine induces antinociception, but prevents opioid-induced constipation and catatonia in rats and precipitates withdrawal in morphine-dependent rats. Life Sci. 1984 Aug 27;35(9):917-27. PubMed PMID: 6381949. 2. Simonin F, Slowe S, Becker JA, Matthes HW, Filliol D, Chluba J, Kitchen I, Kieffer BL. Analysis of [3H]bremazocine binding in single and combinatorial opioid receptor knockout mice. Eur J Pharmacol. 2001 Mar 2;414(2-3):189-95. PubMed PMID: 11239918. 3. Dortch-Carnes J, Potter DE. Bremazocine: a kappa-opioid agonist with potent analgesic and other pharmacologic properties. CNS Drug Rev. 2005 Summer;11(2):195-212. Review. PubMed PMID: 16007240. 4. Shearman GT, Stenfors C. Bremazocine-induced backwards walking behavior in rats is mediated via opioid kappa receptors. Pharmacol Biochem Behav. 1986 Apr;24(4):861-3. PubMed PMID: 3012599.